HUTCHMED (China) (HCM) EPS (Diluted) Growth (1y) (2015 - 2021)
HUTCHMED (China) (HCM) EPS (Diluted) Growth (1y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 141.94% |
| Mar 31, 2021 | 47.93% |
| Jun 30, 2020 | 123.12% |
| Mar 31, 2020 | -20.82% |
| Dec 31, 2019 | -275.84% |
| Sep 30, 2019 | -367.72% |
| Jun 30, 2019 | -241.73% |
| Mar 31, 2019 | 239.95% |
| Dec 31, 2018 | 69,451.62% |
| Dec 31, 2017 | 111.36% |
| Dec 31, 2016 | -41.27% |
| Jun 30, 2016 | 13.62% |
| Dec 31, 2015 | 94.97% |